Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

726 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
NYVAC immunization induces polyfunctional HIV-specific T-cell responses in chronically-infected, ART-treated HIV patients.
Harari A, Rozot V, Cavassini M, Bellutti Enders F, Vigano S, Tapia G, Castro E, Burnet S, Lange J, Moog C, Garin D, Costagliola D, Autran B, Pantaleo G, Bart PA. Harari A, et al. Among authors: costagliola d. Eur J Immunol. 2012 Nov;42(11):3038-48. doi: 10.1002/eji.201242696. Epub 2012 Oct 1. Eur J Immunol. 2012. PMID: 22930439 Free article. Clinical Trial.
HIV type 1-specific IgG2 antibodies: markers of helper T cell type 1 response and prognostic marker of long-term nonprogression.
Ngo-Giang-Huong N, Candotti D, Goubar A, Autran B, Maynart M, Sicard D, Clauvel JP, Agut H, Costagliola D, Rouzioux C; French Asymptomatic Long-Term Study Group. Ngo-Giang-Huong N, et al. Among authors: costagliola d. AIDS Res Hum Retroviruses. 2001 Oct 10;17(15):1435-46. doi: 10.1089/088922201753197105. AIDS Res Hum Retroviruses. 2001. PMID: 11679156
Interleukin-2 accelerates CD4 cell reconstitution in HIV-infected patients with severe immunosuppression despite highly active antiretroviral therapy: the ILSTIM study--ANRS 082.
Katlama C, Carcelain G, Duvivier C, Chouquet C, Tubiana R, De Sa M, Zagury L, Calvez V, Autran B, Costagliola D; ILSTIM. Katlama C, et al. Among authors: costagliola d. AIDS. 2002 Oct 18;16(15):2027-34. doi: 10.1097/00002030-200210180-00007. AIDS. 2002. PMID: 12370501 Clinical Trial.
Increase of HIV-1 pro-viral DNA per million peripheral blood mononuclear cells in patients with advanced HIV disease (CD4<200 cells/mm3) receiving interleukin 2 combined with HAART versus HAART alone (ANRS-082 trial).
Delaugerre C, Gourlain K, Tubiana R, Carcelain G, Marcelin AG, Chouquet C, Mouroux M, Duvivier C, Autran B, Costagliola D, Katlama C, Calvez V. Delaugerre C, et al. Among authors: costagliola d. Antivir Ther. 2003 Jun;8(3):233-7. Antivir Ther. 2003. PMID: 12924540 Clinical Trial.
Evaluating therapeutic vaccines in patients infected with HIV.
Autran B, Costagliola D, Murphy R, Katlama C. Autran B, et al. Among authors: costagliola d. Expert Rev Vaccines. 2004 Aug;3(4 Suppl):S169-77. doi: 10.1586/14760584.3.4.s169. Expert Rev Vaccines. 2004. PMID: 15285715 Review.
726 results